| Literature DB >> 22264330 |
Imen Aissa1, Rabiaa Manel Sghair, Mohamed Bouaziz, Dhafer Laouini, Sami Sayadi, Youssef Gargouri.
Abstract
BACKGROUND: Preparation of tyrosyl lipophilic derivatives was carried out as a response to the food, cosmetic and pharmaceutical industries' increasing demand for new lipophilic antioxidants.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22264330 PMCID: PMC3292923 DOI: 10.1186/1476-511X-11-13
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Figure 1Structure of Synthesized Compounds.
1H NMR Data (300 MHz, CDCL3) for Compounds Ty to TyC
| (Ty) | (TyC2) | (TyC3) | (TyC8) | (TyC10) | (TyC12) | (TyC16) | (TyC18) | (TyC18: 1) | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3.72 (t) | 4.26 (t) | 4.26 (t) | 4.28 (t) | 4.24 (t) | 4.25 (t) | 4.31 (t) | 4.23 (t) | 4.23 (t) |
| 2 | 2.71 (t) | 2.87 (t) | 2.87 (t) | 2.87 (t) | 2.85 (t) | 2.85 (t) | 2.92 (t) | 2.85 (t) | 2.82 (t) |
| 4 | 7.11 (d) | 7.10 (d) | 7.07 (d) | 7.08 (d) | 7.06 (d) | 7.04 (d) | 7.12 (d) | 7.07 (d) | 7.09 (d) |
| 5 | 6.79 (d) | 6.80 (d) | 6.80 (d) | 6.80 (d) | 6.79 | 6.80 (d) | 6.80 (d) | 6.80 (d) | 6.80 (d) |
| 6 | 5.50 (s) | 5.50 (s) | 5.50 (s) | 5.50 (s) | 5.50 (s) | 6.00(s) | 5.10 (s) | 5.30 (s) | |
| 2' | 2.06 (s) | 2.32(q) | 2.33(t) | 2.29 (t) | 2.30(t) | 2.36(t) | 2.30(t) | 2.30(t) | |
| 3' | 1.13 (t) | 1.60(m) | 1.59 (m) | 1.60 (m) | 1.66(m) | 1.60 (m) | 1.60 (m) | ||
| 4' | 1.28(m) | 1.25 (m) | 1.26 (m) | 1.32 (m) | 1.25 (m) | 1.25 (m) | |||
| (CH2)3 | 1.28(m) | 1.25 (m) | 1.26 (m) | 1.32 (m) | 1.25 (m) | 1.25 (m) | |||
| 8' | 0.9 (t) | 1.25 (m) | 1.26 (m) | 1.32 (m) | 1.25 (m) | 2.00 (m) | |||
| 9' | 1.25 (m) | 1.26 (m) | 1.32 (m) | 1.25 (m) | 5.33 (m) | ||||
| 10' | 0.88 (t) | 1.26 (m) | 1.32 (m) | 1.25 (m) | 5.33 (m) | ||||
| 11' | 1.26 (m) | 1.32 (m) | 1.25 (m) | 2.00 (m) | |||||
| 12' | 0.88 (t) | 1.32 (m) | 1.25 (m) | 1.25 (m) | |||||
| 13' | 1.32 (m) | 1.25 (m) | 1.25 (m) | ||||||
| 14' | 1.32 (m) | 1.25 (m) | 1.25 (m) | ||||||
| (CH2)n | 1.32 (m) | 1.25 (m) | 1.25 (m) | ||||||
| Me | 0.94 (t) | 0.87 (t) | 0.87 (t) | ||||||
13C NMR Chemical Shifts (ppm) (125
| (Ty) | (TyC2) | (TyC3) | (TyC8) | (TyC10) | (TyC12) | (TyC16) | (TyC18) | (TyC18: 1) | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 63.1 | 65.7 | 65.6 | 65.9 | 65.3 | 63.7 | 65.6 | 65.6 | 65.7 |
| 2 | 37.2 | 34.6 | 34.6 | 34.6 | 34.4 | 32.7 | 34.8 | 34.8 | 35.0 |
| 3 | 130.6 | 130.2 | 130.12 | 129.6 | 129.9 | 127.5 | 129.9 | 129.9 | 130.9 |
| 4 | 131.3 | 130.4 | 130.41 | 130.3 | 129.4 | 128.2 | 130.3 | 130.3 | 130.07 |
| 5 | 115.7 | 115.8 | 115.7 | 115.9 | 115.4 | 113.7 | 115.7 | 115.7 | 116.1 |
| 6 | 154.1 | 154.8 | 154.8 | 155.2 | 154.7 | 153.1 | 154.9 | 154.9 | 155.4 |
| 1' | 171.9 | 174.1 | 175.4 | 174.7 | 173.1 | 174.9 | 174.4 | 174.6 | |
| 2' | 21.4 | 30.09 | 34.8 | 34.3 | 32.7 | 34.6 | 34.6 | 32.6 | |
| 3' | 28.04 | 25.3 | 31.9 | 23.2 | 25.3 | 25.34 | 25.7 | ||
| 4' | 29.4-29.2 | 29.4-29.1 | 27.9-27.4 | 29.5-30.1 | 29.5-30.1 | 29.8-28.0 | |||
| (CH2)3 | 29.4-29.2 | 29.4-29.1 | 27.9-27.4 | 29.5-30.1 | 29.5-30.1 | 29.8-28.0 | |||
| 8' | 14.4 | 24.8 | 27.9-27.4 | 29.5-30.1 | 29.5-30.1 | 27.2 | |||
| 9' | 22.6 | 27.9-27.4 | 29.5-30.1 | 29.5-30.1 | 129.8 | ||||
| 10' | 14.1 | 32.5 | 29.5-30.1 | 29.5-30.1 | 128.0 | ||||
| 11' | 21.0 | 29.5-30.1 | 29.5-30.1 | 27.2 | |||||
| 12' | 12.43 | 29.5-30.1 | 29.5-30.1 | 29.8-28.0 | |||||
| 13' | 29.5-30.1 | 29.5-30.1 | 29.8-28.0 | ||||||
| 14' | 32.3 | 29.5-30.1 | 29.8-28.0 | ||||||
| 15' | 23.1 | 29.5-30.1 | 29.8-28.0 | ||||||
| 16' | 14.5 | 32.3 | 31.9 | ||||||
| 17' | 23.09 | 23.4 | |||||||
| 18' | 14.5 | 14.8 | |||||||
Inhibitory spectrum of tyrosol (Ty) and tyrosyl esters on Gram-positive and Gram-negative bacteria
| Strain | Gram | Sensibility | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| + | - | - | - | - | - | - | - | |||
| + | - | - | - | - | - | - | - | - | ||
| + | - | - | - | - | - | - | - | - | - | |
| + | - | - | - | - | - | - | - | |||
| + | - | - | - | - | - | - | - | - | - | |
| + | - | - | - | - | - | - | ||||
| + | - | - | - | - | - | - | ||||
| + | - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | |||
| - | - | - | - | - | - | - | - | |||
| - | - | - | - | - | - | - | - | |||
| - | - | - | - | - | - | - | - | |||
| - | - | - | - | - | - | - | - | |||
The bactericidal level was estimated by measuring the size of inhibition zone of the indicator strain. Insensitivity (-), low sensitivity (+: Diameter of inhibition < 15 mm), high sensitivity (++: Diameter of inhibition between 15 et 20 mm)
Minimum inhibitory concentrations (MIC) of Tyrosol (Ty) and Tyrosyl esters (TyC, TyCand TyC) for three microbial strains after 24 h of incubation at 37°C.
| Compounds | MIC (μg/mL) | ||
|---|---|---|---|
| S. | S. | B. | |
| Ty | ND | ND | ND |
| TyC8 | 25 | 25 | 12.5 |
| TyC10 | 12.5 | 12.5 | 3.1 |
| TyC12 | 50 | 50 | > 100 |
ND*: Without effect up to 5 mg/ml.
IC50 activities of tyrosol and its acyl chain derivatives against L. major and L. infantum parasite species evaluated by the MTT assay
| Compounds | Ty | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| IC50 (μg/ml) | ND | ND | ND | ND | ND | ND | |||
| IC50 (μg/ml) | ND | ND | ND | ND | ND | ND | |||
* ND: Without effect up to 400 μg/ml
Figure 2Acyl chain length of each tyrosyl derivatives plotted relatively to (A) MIC values obtained on staphylococcus strains (black diamonds) or to (B) IC.